D. Van Raemdonck (Leuven, Belgium), S. Harari (Milan, Italy)
Strict antifungal prophylaxis reduces the risk of invasive fungal infections after lung transplantation (LTx)
S. Irani, R. Speich, S. Schneider, K. Remund, C. Eich, W. Weder, A. Boehler (Zurich, Switzerland)
|  |
Lung transplantation and emerging fungal infections: another challenge for late survival
P. Morales, J. Pemán, A. Solé, A. Pastor, L. Amsalem, J. Ros (Valencia, Murcia, Spain)
| |
Pulmonary cladophialophora boppii infection in a lung transplant recipient
C. Lastoria, A. Cascina, F. Bini, A. Di Matteo, C. Cavanna, E. Carretto, F. Meloni, T. Oggionni (Pavia, Italy)
| |
Prolonged oral ganciclovir (GCV) reduces the incidence of CMV infection and disease after lung transplantation (LTx)
M. Hofer, R. Speich, C. Chmiel, D. Ritscher, W. Weder, A. Boehler (Zurich, Switzerland)
| |
A follow-up study with broncho-alveolar lavage (BAL) to assess the importance of airway colonization in lung transplantation (LTx)
B. M. Vanaudenaerde, L. L. Dupont, N. Geudens, D. E. M. Van Raemdonck, G. M. Verleden (Leuven, Belgium)
| |
Broncho-alveolar lavage fluid recovery (BFR) predicts rejection in lung transplantation
B. M. Vanaudenaerde, L. J. Dupont, N. Geudens, D. E. M. Van Raemdonck, G. M. Verleden (Leuven, Belgium)
| |
Calcineurin inhibitors do not affect the expansion of CD4+CD25+ Treg cells in peripheral blood of lung transplant recipients
F. Meloni, M. Morosini, N. Solari, F. Bini, P. Vitulo, E. Arbustini, C. Pellegrini, A. M. Fietta (Pavia, Italy)
| |
Serum CA 19-9 in lung allograft recpients
I. A. Forrest, C. Ward, D. M. Murphy, G. E. Johnson, P. A. Corris (Newcastle upon Tyne, United Kingdom)
| |
Validation of a bronchiolitis obliterans rat lung transplant model: the role of MMP-9
K. Krenn, P. Paulus, N. Sela, L. Masurova, S. Taghavi, S. Aharinejad (Vienna, Austria)
| |
The lectin-like domain of thrombomodulin supresses leukocyte lung infiltration in a murine ischemia-reperfusion injury model
N. Geudens, M. Van de Wouwer, B. M. Vanaudenaerde, A. P. Neyrinck, F. R. Rega, C. Van De Wauwer, T. Lerut, E. Verbeken, G. M. Verleden, E. Conway, D. E. M. Van Raemdonck (Leuven, Belgium)
| |
Keratinocyte growth factor (rHuKGF) increases surfactant protein A in rats and prevents alveolar oedema after orthotopic rat lung transplantation
H. Fehrenbach, J. Sadovski, A. Fehrenbach, E. Dietzel, S. Blöcher, R. Naumann, T. Rausch, W. Padberg, V. Grau (Marburg, Giessen, Germany)
| |
Development of bronchiolitis obliterans (BO) using different cyclosporine A based immunosuppressive regimens in both genders in rat trachea grafts
V. Müller, D. Yang, A. Vannay, A. J. Szabo, A. Nagy, R. Langer, G. Losonczy, P. Magyar (Budapest, Hungary; Dalian, China)
| |
Inflammative responses during reperfusion after cold preservation in the isolated and ventilated perfused rat lung
C. Hanusch, K. Nowak, I. I. S. Gill, P. Toerlitz, P. Hohenberger, B. Yard, B. C. Grietje (Mannheim, Germany)
| |
Ophthalmologic disease after lung transplantation
K. F. Remund, R. Kovacs, S. Colombo, W. Walter Weder, R. Speich, A. Boehler (Zurich, Switzerland)
| |
Glucose tolerance, beta-cell function and insulin sensitivity in cystic fibrosis patients awaiting lung transplantation
A. Klarer, M. Hofer, P. Wiesli, C. Schmid, A. Boehler (Zurich, Switzerland)
| |
Quality of life in live-donor lung transplants in Brazil
L. M. Correa da Silva, S. Camargo, J. Bellicanta (Porto Alegre, Brazil)
| |
Predictors for long-term health related quality of life after lung transplantation; do they differ between physical and psychological dimensions?
K. M. Vermeulen, W. van der Bij, E. M. TenVergert (Groningen, Netherlands)
| |
Pediatric lung transplantation: a single center experience
A. Moreno, J. Maestre, S. Liñan, S. Gartner, J. Balcells, C. Marhuenda, J. Sole, N. Cobos, V. Monforte, G. Vizmanos, N. Montferrer (Barcelona, Spain)
| |